Need help?

Pharmaceutical Business Investment Opportunities

Showing 43 - 56 of 171 Pharmaceutical Business Investment Opportunities. Invest in a Pharmaceutical, Alternative Medicine, Biopharmaceutical, Diagnostic Substance Manufacturing, Generic Pharmaceutical, Specialty Pharmaceutical, Veterinary Drug, Nutraceutical or a Pharma Marketing Business. Listed by Direct Business Owners & Business Brokers.
Filters
  • Pharmaceuticals

  • Investment Opportunities

 

Profitable Specialty Pharmaceuticals Business Investment Opportunity in Jassur, India

Himachal Pradesh-based pharmaceutical manufacturer, seeking investment for expansion: strong ties with Fortis and Tata 1mg.
The business is a pharmaceutical manufacturer based out of Jassur, Himachal Pradesh. - Distributing products through a network of six distributors. - Company has established strategic partnerships and distribution channels, as evidenced by its recent deal with Fortis and its tie-up with Tata 1mg. - With a strong online presence, the business has listed its products on Amazon, showcasing its commitment to leveraging e-commerce platforms for sales and visibility. - The company has effectively outsourced its manufacturing operations, potentially offering flexibility and cost-efficiency in production. - The business benefits from the expertise of its promoter, who brings 24 years of experience in the industry and holds an MSc in medicine, specializing in the formulation of medicines. - The company holds multiple certifications, including FDA-approved products, WHO-GMP certification, UKAI certification, ISO 9001:2015, and MSME certification, demonstrating a commitment to quality and compliance with international standards.
Himachal Pradesh-based pharmaceutical manufacturer, seeking investment for expansion: strong ties with Fortis and Tata 1mg.
6.6   Jassur
Run Rate Sales
USD 42 thousand
EBITDA Margin
30 - 40 %
Partial Stake Sale
USD 58 K for 30%
Contact Business

Newly Established Nutraceuticals Company Investment Opportunity in Bhubaneswar, India

Seeking funding for drug-development in Bhubaneswar, specializing in nitric oxide induction, with patented research findings.
Business is located in Bhubaneswar, specializing in the development of drugs that induce endogenous nitric oxide in humans and animals. - Company is incubated in a well-known biotechnological institute in Bhubaneswar, Orissa. - Company has successfully completed the research to identify the chemical structure of the drug that can induce nitric oxide production and is now seeking funding to proceed with development. - Research findings are patented and protected in India, USA, and EU, providing the company with a competitive advantage in the market. - The company is ready to commence the development phase upon securing the necessary funding, presenting an opportunity for potential investors to participate in an innovative and potentially lucrative venture in the pharmaceutical and nutraceutical industry. - Promoter is a medical researcher and has 50 years of experience. - The company is registered with the Ministry of Corporate Affairs (MCA), ensuring compliance with regulatory and legal requirements.
6.9   Bhubaneswar
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 1 Mn for 10%
Contact Business

Profitable Pharma Marketing Company Investment Opportunity in Mumbai, India

Mumbai-based pharma marketing with 200 plus clients in northern India planning a new product launch.
1. The business operates in the pharma marketing industry, with its base in Mumbai, India. 2. Currently, the business has 7 employees and primarily deals in the sales of antibiotics, which is its most sold product. 3. Its primary clientele consists of general physicians across northern India, and it has over 200 clients in the region. 4. In addition to antibiotics, the business also offers multivitamins to its customers. 5. The business is looking to expand its product line by launching neurological and orthopaedic products, with an estimated timeline of 3-6 months for full establishment. 6. Product manufacturing is outsourced, and the manufacturers hold the requisite manufacturing and FSSAI licenses. 7. On a quarterly basis, the business sells over 500 boxes of its pharmaceutical products.
7.5   Mumbai
Run Rate Sales
USD 55 thousand
EBITDA Margin
40 %
Partial Stake Sale
USD 46 K for 20%
Contact Business
List your business on SMERGERS.
Get visibility from 110,000+ member network of Businesses, Investors, Acquirers, Lenders and Advisors from 900+ Industries and 170+ Countries
Create Business Profile

Profitable Pharma Marketing Company Investment Opportunity in Mumbai, India

Mumbai-based pharma marketing with 200 plus clients in northern India planning a new product launch.
1. The business operates in the pharma marketing industry, with its base in Mumbai, India. 2. Currently, the business has 7 employees and primarily deals in the sales of antibiotics, which is its most sold product. 3. Its primary clientele consists of general physicians across northern India, and it has over 200 clients in the region. 4. In addition to antibiotics, the business also offers multivitamins to its customers. 5. The business is looking to expand its product line by launching neurological and orthopaedic products, with an estimated timeline of 3-6 months for full establishment. 6. Product manufacturing is outsourced, and the manufacturers hold the requisite manufacturing and FSSAI licenses. 7. On a quarterly basis, the business sells over 500 boxes of its pharmaceutical products.
7.5   Mumbai
Run Rate Sales
USD 55 thousand
EBITDA Margin
40 %
Partial Stake Sale
USD 46 K for 20%
Contact Business

Medical Equipment Wholesale Business Investment Opportunity in Pune, India

Seeking investment to expand pharmaceutical-exports to 4 countries, aiming for INR 100 crores in revenue.
The business operates in the pharmaceutical and medical devices export industry, focusing on therapies such as anaemia management, nephrology, and gynaecology. - With a current staff of 6 permanent employees, the business has made significant strides in increasing its client base, growing from 2 clients in the last fiscal year to 15 clients in the current fiscal year. - The company has outlined a road-map to achieve a turnover of 100 crore in the next 2 fiscal years, indicating a strong growth trajectory. - Initially starting as a short-term trading model, the business is now transitioning towards brand building and is in the process of registering its brand in 4 countries, showcasing a strategic shift in its business model. - The product portfolio comprises 80% medicines and 20% medical devices, with a focus on exporting these products to countries such as Zambia, Uganda, and Kenya. - The business sources medicines and equipment from India and exports them to international markets, highlighting its role in facilitating the global distribution of pharmaceutical and medical devices. - With a valid GST certificate for operations, the business is compliant with regulatory requirements, adding a layer of credibility to its operations.
8.4   Pune
Run Rate Sales
USD 83 thousand
EBITDA Margin
20 %
Partial Stake Sale
USD 173 K for 15%
Contact Business

Generic Pharmaceuticals Business Investment Opportunity in Panchkula, India

Unique drug wholesaler with established client base and experienced owner seeks partial stake sale.
1. Niche focus: The business specializes in the distribution of unique medicines aimed at countering arthritis and protein powders among other products. This niche focus provides a competitive advantage in the generic pharmaceutical industry. 2. Established client base: With over 100 wholesale clients, the company has built a strong and diverse customer base, indicating a positive reception of its products in the market. 3. Revenue generation: The business generated approximately INR 1 crore in revenue in the last financial year, reflecting its ability to generate substantial sales within a competitive market. 4. Experienced owner: The owner of the business brings over 8 years of valuable experience in the pharmaceutical industry, contributing to the strategic management and growth potential of the company. 5. Product source: The company's products are manufactured by a sister concern, ensuring a streamlined and controlled supply chain and potentially reducing production costs. The business just ran for a few months last year and this will be the first complete calendar year for the business.
Unique drug wholesaler with established client base and experienced owner seeks partial stake sale.
6.2   Panchkula
Run Rate Sales
USD 166 thousand
EBITDA Margin
10 %
Partial Stake Sale
USD 17.3 K for 50%
Contact Business

Alternative Medicine Business Investment Opportunity in Dehradun, India

Herbal extracts and nutraceuticals provider seeking investment for expansion into manufacturing and export markets.
The business provides herbal extracts, raw herbs and nutraceuticals to clients through third-party manufacturing. - Products include omega-3 fatty acids, gymnema extract, ashwagandha, berberine, guggul extract, boswellia, garlic, and ginger extract. - Business currently serves over 10 clients, with bulk orders from regular clients that vary in size. - Staffing is managed on a flexible basis, with day wage workers hired according to order volume. - The business holds an FSSAI license, GST registration, and is registered under MSME.
6.3   Dehradun
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 220 K for 49%
Contact Business

Newly Established Nutraceuticals Company Investment Opportunity in Hatod, India

Nutraceutical startup seeking investment for establishing a pharmaceutical manufacturing unit and acquiring machinery.
With 16 years of extensive experience in pharmaceutical research and manufacturing, the owner is transitioning into entrepreneurship to establish a manufacturing company specializing in Nutraceuticals and Pharmaceuticals products. - Currently, we are actively seeking investors to facilitate the construction of our manufacturing facility and the procurement of essential machinery. - Land has already been allocated for our manufacturing factory dedicated to Nutraceuticals and Pharmaceuticals products. - Currently, the business is registered and intends to obtain additional licenses following the construction of the manufacturing facility. - The registered office address is in Rewa, but our manufacturing unit will be based in Hatod.
Nutraceutical startup seeking investment for establishing a pharmaceutical manufacturing unit and acquiring machinery.
8.1   Hatod
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 58 K for 10%
Contact Business

Profitable Diagnostic Substances Manufacturing Company Investment Opportunity in Bhopal, India

FDA, WHO, and ISO compliant company manufacturing high-quality in vitro diagnostic products, clinical chemistry reagents.
The company specializes in manufacturing high-quality in vitro diagnostic products, clinical chemistry reagents and rapid diagnostic tests. - The company serves over 100 clients, including hospitals, diagnostic laboratories, and POCT providers. - Our revenue model includes direct sales to healthcare institutions and laboratories. - We engage in B2B sales of uncut sheets of urine strips to other manufacturers. - Company forms OEM partnerships and offers custom packaging solutions for clients. - We also conduct sales through distributors and marketing partners. - Our promoters bring over three decades of expertise in the healthcare industry, specializing in the development and production of in vitro diagnostic products. - We have a strong background in quality assurance, adhering to ISO 13485:2016 and GMP standards. - The company is ISO 13485:2016 and GMP certified. - We hold a startup certificate and are selected under the BIRAC scheme for innovative product development. - The company collaborates with academic and research institutions, including a notable partnership with IIT Kanpur for developing a TB RT-PCR kit under the BIRAC scheme. - Our product range includes a comprehensive array of clinical diagnostic reagents and test kits. - We offer custom packaging options tailored to client requirements. - Company is committed to continuous improvement and total quality assurance. - Our highlights showcase our dedication to delivering superior-quality diagnostic products, fostering strong industry relationships, and maintaining a robust quality management system. - We boast a state-of-the-art manufacturing plant in Bhopal, fully compliant with Indian FDA, WHO, and ISO 13485 standards. - Our manufacturing capacity includes: - Rapid Card: 5 million tests/month. - Biochemistry: 10,000 liters of reagents/month. - Hematology: 25,000 liters of reagents/month. - Urine Strip: 300,000 strips/day. - The company has a highly motivated and experienced team excelling in manufacturing, quality control, regulatory compliance, and supply chain management. - We have a provision for a 3-row assembly room, ensuring efficient and reliable production to meet extensive testing capabilities. - Our facility is a testament to our commitment to high-quality manufacturing and our readiness to seize future business opportunities while maintaining the highest standards of compliance and efficiency.
FDA, WHO, and ISO compliant company manufacturing high-quality in vitro diagnostic products, clinical chemistry reagents.
8.7   Bhopal
Run Rate Sales
USD 194 thousand
EBITDA Margin
40 %
Partial Stake Sale
USD 470 K for 50%
Contact Business

Generic Pharmaceuticals Company Investment Opportunity in Simi Valley, USA

Company specializing in developing innovative headache remedies, seeking investment for expansion of distribution channels.
The company has developed remedies for headache, hangover, and migraine, positioning itself as an innovator in the market. - Manufactured and sold under its own brand name. - Currently, in the "soft" launch phase in 100 locations nationwide, the company is selling through a distribution network to pharma retail outlets such as CVS and Walmart. - The business is experiencing a high level of satisfaction and repeat buyers, indicating a strong market response to its products. - With established relationships and a sales team, the company aims to expand to hundreds of thousands of locations nationally, with a focus on e-commerce due to high margins and a product that aligns well with the subscription model for consistent repeat sales. - With over 16 years of experience in the pharma industry, the company has expertise in running a successful subscription business model, positioning it for long-term success. - The product is registered as a dietary supplement under the FDA. - There are 11 permanent employees who are necessary for running the business operations, employed in production, admin, management, sales & marketing sectors.
Company specializing in developing innovative headache remedies, seeking investment for expansion of distribution channels.
7.3   Simi Valley
Run Rate Sales
USD 12 thousand
EBITDA Margin
40 %
Partial Stake Sale
USD 500 K for 15%
Contact Business

Profitable Alternative Medicine Company Investment Opportunity in Ahmedabad, India

Re-established Ayurvedic medicine business in Ahmedabad, India that offers innovative products.
The business operates in the alternative medicine industry, specifically focusing on Ayurvedic medicine. - The business is located in Ahmedabad, a prominent city in the state of Gujarat, India. - Business offers a range of products including Sanjivani capsule, sugar control capsule and Power, immunity booster capsule, and D-Boost capsule. - The business currently has a small team of 3 employees. - Business requires at least 5 years of experience in Ayurveda practice and 2 years of experience in Ayurveda shops. Additionally, a GST and drugs license or food license is required, along with a BAMS (Bachelor of Ayurvedic Medicine and Surgery) degree. - After being closed for the last 3 years, the business has restarted its operations in April of this year. - The business holds 42 patent permissions, indicating a strong focus on innovation and intellectual property. - Business operates on a B2B model, catering to other businesses within the alternative medicine industry. - The business has acquired a valid drug license for operations in India.
6.5   Ahmedabad
Run Rate Sales
USD 14 thousand
EBITDA Margin
40 %
Partial Stake Sale
USD 116 K for 25%
Contact Business

Small Alternative Medicine Business Investment Opportunity in Bhiwandi, India

Bhiwandi based unani and ayurvedic products manufacturing company with 5-10 distributors across India.
The company is located in Bhiwandi and manufactures ayurvedic massage and hair oil. - It has a distribution network spanning across India, with 5-10 distributors servicing various regions including Mumbai, Uttar Pradesh, Gujarat, Nagpur, MP, Nashik, Pune, and Hyderabad. - Majority of the sales however are within Mumbai. - The best-selling product, Lal Tel, is a popular pain relief and massage oil used for joints, knees, shoulders, and back, catering to the market demand for natural remedies and traditional pain relief solutions. - The product portfolio includes hair oil for dandruff control and strong hair growth, catering to the growing demand for natural and holistic hair care solutions in the market. - There has been a significant drop in sales this year due to a lack of capital which led to a fall in procurement of raw materials and reduced production. - The company holds a drug license, indicating compliance with regulatory requirements and providing a competitive advantage in the market. - With a current staff of 5 employees, including the owner and sales and marketing personnel, the company is positioned for growth and expansion. - Despite the current lack of profitability due to capital constraints, the company anticipates a turnaround with the infusion of funding, projecting future profits within the next few months.
Bhiwandi based unani and ayurvedic products manufacturing company with 5-10 distributors across India.
6.4   Bhiwandi
Run Rate Sales
USD 9.7 thousand
EBITDA Margin
Nil
Partial Stake Sale
USD 5.8 K for 10%
Contact Business

Pharma Marketing Company Investment Opportunity in Ranchi, India

Pharma marketing company with 5 manufacturers and a significant network of 200 doctors.
The company specializes in trading of diabetic medicine and currently sells a total of 13 products, including Mecorian plus, Ribamet range, Abriplex-L, Rabian Dsr, Abriprot, Abricort, and L-Carian Q10. - The business has a diverse sourcing strategy, with tie-ups with 5 manufacturers from whom products are sourced. - Its primary revenue stream is derived from doctors prescribing its medicine, with a substantial presence in Bihar and Jharkhand, supplying to approximately 200 doctors. - In addition to the doctor network, the company also distributes a small portion of its products to retailers and chemists in the region. - The company is headquartered in Ranchi, a strategic location within the pharmaceutical industry, allowing for convenient access to the Bihar and Jharkhand markets. - With a relatively small team of 8 employees that includes 2 owners and the sales and marketing department, the company has been able to establish a strong presence in the pharmaceutical sector in the region. - We have the necessary drug license to run this business.
Pharma marketing company with 5 manufacturers and a significant network of 200 doctors.
6.7   Ranchi
Run Rate Sales
USD 42 thousand
EBITDA Margin
30 %
Partial Stake Sale
USD 35 K for 30%
Contact Business

Newly Established Diagnostic Substances Manufacturing Company Investment Opportunity in Calgary, Canada

Radiology imaging drug manufacturing company based in Alberta, seeking investment for establishing manufacturing facility.
Company based in Calgary, Alberta focused on the manufacturing and sales of radiology imaging drugs, with a specific emphasis on barium contrast drugs used by both private and government healthcare facilities in the radiology industry, currently in the pre-revenue stage. - The company is in the process of developing iodine drugs and creating new endohedral fullerene drugs from captured CO2, targeting a market valued at $6.5 billion. - With plans to commence operations this year, the company emphasizes the strategic importance of critical minerals required for the creation of radiology drugs, and it possesses its own resources, enabling it to vertically integrate its radiology drug business. - Aspiring to become the first vertically-integrated North American supplier of medical imaging contrast agents, the company is focused on producing a line of generic and new innovative barium and iodine radiology imaging contrast media products. Additionally, involved in the development of a new carbon fullerene drug for magnetic resonance imaging (MRI). - These products will be supplied to healthcare and imaging facilities. The first contract was signed for USD 1.9M. - Business has 5 Health Canada drug licenses, partnership and exclusive rights to develop endohedral fullerene drugs for the radiology imaging market, and a carbon capture program for future carbon revenue generation.
6.8   Calgary
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 2.9 Mn for 26%
Contact Business

Nutraceuticals Company Investment Opportunity in Noida, India

Nutraceuticals D2C brand in Noida with 250 daily orders and celebrity endorsements seeks investment.
The business is based in Noida and operates in the nutraceuticals industry as a direct-to-consumer (D2C) brand, specializing in nutraceutical products. - Key products include gym supplements, weight loss supplements, and shilajit resin, targeting health-conscious consumers. The business also provides additional offerings like vitamins, memory support capsules, and more. - The company reports an average of 250 orders per day. - Products endorsed by celebrities like Karan Singh Grover and Bipasha Basu have enhanced the brand's market visibility and appeal. - With a manufacturing capacity of 5,000 units, the company also outsources production to fulfill demand. - The company sells its products on various online platforms, including Amazon, Flipkart, Tata 1MG etc. - The business holds all necessary licenses, including GST, Udyam, and FSSAI, ensuring compliance and credibility in its operations.
5.6   Noida
Run Rate Sales
USD 280 thousand
EBITDA Margin
30 %
Partial Stake Sale
USD 230 K for 10%
Contact Business
Frequently
Asked
Questions
  • How many pharmaceutical business investment opportunities are listed on SMERGERS?
    There are 171 active and verified pharmaceutical business investment opportunities listed on SMERGERS as of 28 July 2025.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more